In addition to its direct anti-tumor effects, iEV-150 promoted CD8+ T cell infiltration and activation within the tumor microenvironment, and significantly enhanced the therapeutic efficacy of ICB in melanoma models. The gene discussed is CD8A; the disease is melanoma.